Tempest Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. 

CEO
Matthew Angel
CEOMatthew Angel
Employees
4
Employees4
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2011
Founded2011
Employees
4
Employees4

TPST Key Statistics

Market cap
15.98M
Market cap15.98M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
2.89M
Average volume2.89M
High today
$1.22
High today$1.22
Low today
$0.9675
Low today$0.9675
Open price
$1.07
Open price$1.07
Volume
57.07M
Volume57.07M
52 Week high
$12.23
52 Week high$12.23
52 Week low
$0.7432
52 Week low$0.7432

Stock Snapshot

As of today, Tempest Therapeutics(TPST) shares are valued at $1.00. The company's market cap stands at 15.98M, with a P/E ratio of -0.17.

During the trading session on 2026-09-16, Tempest Therapeutics(TPST) shares reached a daily high of $1.22 and a low of $0.97. At a current price of $1.00, the stock is +3.4% higher than the low and still -18.0% under the high.

Trading volume for Tempest Therapeutics(TPST) stock has reached 57.07M, versus its average volume of 2.89M.

Over the past 52 weeks, Tempest Therapeutics(TPST) stock has traded between a high of $12.23 and a low of $0.74.

Over the past 52 weeks, Tempest Therapeutics(TPST) stock has traded between a high of $12.23 and a low of $0.74.

TPST News

Benzinga 46m
Tempest Therapeutics Stock Surges Wednesday: What's Driving the Action?

Shares of Tempest Therapeutics Inc (NASDAQ:TPST) are trading sharply higher Wednesday morning as investors respond positively to a strategic agreement expanding...

Tempest Therapeutics Stock Surges Wednesday: What's Driving the Action?
Benzinga 12h
Tempest Therapeutics Shares Surge 66.53% After Hours on CAR-T Deal - Tempest Therapeutics - Benzinga

...

Tempest Therapeutics Shares Surge 66.53% After Hours on CAR-T Deal - Tempest Therapeutics - Benzinga
Benzinga 12h
Tempest Therapeutics Stock Climbs Over 66% After Hours: Here's Why

Tempest Therapeutics, Inc. (NASDAQ:TPST) shares soared 66.53% to $1.26 in after-hours trading on Tuesday after the California-based clinical-stage biotechnology...

Tempest Therapeutics Stock Climbs Over 66% After Hours: Here's Why

More TPST News

TipRanks 20h
Tempest Therapeutics Announces New Private Warrant Financing

The latest update is out from Tempest Therapeutics ( (TPST) ). On September 11, 2026, Tempest Therapeutics entered into a securities purchase agreement with an...

People also own

Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.